DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Batroxobin

Batroxobin

  • (12) United States Patent (10) Patent No.: US 6,395,889 B1 Robison (45) Date of Patent: May 28, 2002

    (12) United States Patent (10) Patent No.: US 6,395,889 B1 Robison (45) Date of Patent: May 28, 2002

  • Cross-Linking of Alpha 2-Plasmin Inhibitor to Fibrin by Fibrin- Stabilizing Factor

    Cross-Linking of Alpha 2-Plasmin Inhibitor to Fibrin by Fibrin- Stabilizing Factor

  • Serine Proteases with Altered Sensitivity to Activity-Modulating

    Serine Proteases with Altered Sensitivity to Activity-Modulating

  • Correlation of the Production of Plasminogen Activator with Tumor Metastasis in Bi 6 Mouse Melanoma Cell Lines

    Correlation of the Production of Plasminogen Activator with Tumor Metastasis in Bi 6 Mouse Melanoma Cell Lines

  • Hematology

    Hematology

  • Effect of Intravenous Thrombolysis with Alteplase on Clinical Efficacy

    Effect of Intravenous Thrombolysis with Alteplase on Clinical Efficacy

  • Distinctive Role of Histidine-16 of the B,8 Chain of Fibrinogen in the End-To

    Distinctive Role of Histidine-16 of the B,8 Chain of Fibrinogen in the End-To

  • Exogenous Procoagulant Factors As Therapeutic and Biotechnological

    Exogenous Procoagulant Factors As Therapeutic and Biotechnological

  • Mechanism of Batroxobin Binding to Fibrinogen and Fibrin 1

    Mechanism of Batroxobin Binding to Fibrinogen and Fibrin 1

  • EXPERT COMMITTEE on BIOLOGICAL STANDARDIZATION Geneva, 17 to 21 October 2016

    EXPERT COMMITTEE on BIOLOGICAL STANDARDIZATION Geneva, 17 to 21 October 2016

  • A Quantitative and Mechanistic Assessment of Activated Thrombin- Activatable Fibrinolysis Inhibitor and Its Role in Pathological Bleeding and Thrombosis

    A Quantitative and Mechanistic Assessment of Activated Thrombin- Activatable Fibrinolysis Inhibitor and Its Role in Pathological Bleeding and Thrombosis

  • PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev

    PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev

  • Ehealth DSI [Ehdsi V2.2.1] European Commission

    Ehealth DSI [Ehdsi V2.2.1] European Commission

  • December 18, 2017 Siemens Healthcare Diagnostic Products

    December 18, 2017 Siemens Healthcare Diagnostic Products

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Evaluation of Hemostatic Effects of an Adhesive with Recombinant Batroxobin

    Evaluation of Hemostatic Effects of an Adhesive with Recombinant Batroxobin

  • INN Working Document 05.179 Update December 2010

    INN Working Document 05.179 Update December 2010

  • BATROXOBIN VS THROMBIN Thrombin and Batroxobin Are

    BATROXOBIN VS THROMBIN Thrombin and Batroxobin Are

Top View
  • Customs Tariff - Schedule
  • International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
  • (INN) for Biological and Biotechnological Substances
  • Abnormal Hemostasis Screening Tests Leading to Diagnosis of Multiple Myeloma
  • Substantial Equivalence Determination Decision Memorandum
  • Reynaud Ciolek Journal Medicin
  • Clots Are Potent Triggers of Inflammatory Cell Gene Expression Indications for Timely Fibrinolysis
  • THROMBOSIS August 31, 1977 and HAEMOSTASIS Editor: (Formerly Thrombosis Et Diathesis Haemorrhagica) Dr
  • 1 Merideth Addicott Neuroscience Advisor: Dr. Donald Dougherty
  • Thrombin-Like Enzymes in Snake Venoms
  • T. +972-49960595 Email: [email protected] USA: T
  • Rapid Purification of Serine Proteinases from Bothrops
  • New Insights on Moojase, a Thrombin-Like Serine Protease from Bothrops Moojeni Snake Venom
  • December 12, 2016 Siemens Healthcare Diagnostics Products
  • Thrombosis and Cancer:Apersonalview
  • Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation
  • International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
  • Hemostasis Reagents Portfolio Siemens AG Headquarters Siemens Healthcare Diagnostics Inc


© 2024 Docslib.org    Feedback